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Data from the Longitudinal Aging Study Amsterdam were used to study the relationship between neuroticism and
aging. At baseline, cross-sectional analyses of data from 2,117 respondents (aged 55–85 years, M = 70) showed no
significant age differences. The magnitude of the 3- and 6-year stability coefficients was high, and 12% of the
elderly participants showed a clinically relevant mean level change. Longitudinal multilevel analyses showed
a small but statistical significant change with aging, but the mean change was not considered clinically relevant.
A U-formed course was found, showing a slight decrease until respondents reached the age of 70. Adjusting the
model for physical health-related variables slightly increased the stability. An additional interaction analysis
showed that the individual trajectory of neuroticism was not affected by the physical health status. In conclusion,
neuroticism remains rather stable in middle and older adulthood, with some apparent increase in late life.
D OES aging only alter us physically or does ourpersonality change as well? During the past three
decades, the question of whether personality changes in later
life has been the subject of debate in personality research. Some
researchers maintain that personality is fully developed by the
time a person reaches the age of 30 and that it becomes
increasingly stable with time (Costa & McCrae, 1988, 1994;
Costa et al., 2000; Glenn, 1980; Martin, Long, & Poon, 2002;
Roberts & Del Vecchio, 2000). Other researchers advocate the
plasticity of personality as a function of contextual variables
and compensatory behavioral changes to biological aging
(Alwin, 1994; Baltes, Staudinger, & Lindenberger, 1999; Caspi
& Roberts, 1999; Heatherton & Nichols, 1994; Roberts, 1997).
In the present study we aim to examine the cross-sectional and
longitudinal stability or change of the personality trait of
Neuroticism over a 6-year period of time in a large community
sample of Dutch elderly individuals aged between 55 and 85
years at baseline. We hypothesize that we will find general
stability, with a minority showing significant changes in
neuroticism scores in late life.
In general there are two different approaches to the study of
personality stability (Costa & McCrae, 1994): stability of mean
levels to estimate aggregate level changes in personality with
age, and stability approached as an individual-differences
phenomenon, assuming that some people change whereas
many remain stable (Cattell, 1950, 1966; Mroczek & Spiro,
2003). A large body of longitudinal research on mean-level
changes emphasizes the invariance of neuroticism in late life
(Costa & McCrae, 1980, 1990, 1994; Martin et al., 2002; Smith
& Baltes, 1999; Watson & Clark, 1984). However, recent
results suggest that changes can be observed in old age (Small,
Hertzog, Hultsch, & Dixon, 2003).
Studies on individual differences in change are scarce.
A recent study by Mroczek and Spiro (2003) found significant
variability in neuroticism with age. The younger elderly
persons and men who recently experienced a life event showed
a sharp decline in neuroticism over the follow-up period.
Neuroticism is a major personality trait (Eysenck, 1990) and
one of the most well-established dimensions in the ‘‘Big Five’’
(Costa & McCrae, 1994). Research has shown personality in
late life, and neuroticism in particular, to be strongly related to
mental and physical health, level of social support, self-rated
health, and functional limitations (Duberstein et al., 2003;
Hooker, Monahan, Bowman, Frazier, & Shifren, 1998; Siegler
& Brummett, 2000; Smith & Gallo, 2001; Watson & Tellegen,
1985). So, age-graded deteriorations in physical health and
related declines in daily functioning may affect the association
between aging and neuroticism. We hypothesize that these
variables affect the individual trajectories of neuroticism in an
aging population.
For several reasons, this study is rather unique. To our
knowledge, this is the first study to analyze this association in
a large community sample of elderly persons between the ages
of 55 and 85 years at inclusion. Until now, most research has
been performed cross-sectionally or on specific populations. To
analyze the developments of neuroticism in aging populations,
a prospective design is required. As far as we know, this study
is the first using a 6-year longitudinal design with two follow-
up measurements in a community population of elderly
individuals between 55 and 85 years of age. In addition to
this, the multidisciplinary design of this study allowed us to
address the influences of physical health-related variables on
this association. Finally, we are, to our knowledge, the first
researchers looking at individual differences in change on the
longitudinal trajectory of neuroticism in a large community
sample of elderly people.
METHODS
Sampling and Procedures
The present study is part of the Longitudinal Aging Study
Amsterdam (LASA). The LASA is an ongoing multidisciplin-
ary study on predictors and consequences of changes in
physical, cognitive, emotional, and social functioning in older
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people in The Netherlands (Deeg, Knipscheer, & van Tilburg,
1993). Full details on sampling and response are described
elsewhere (Beekman et al, 1995; Penninx et al., 1997). In short,
we drew a random sample of older (55–85 years) men and
women from the population registers in eleven municipalities in
three geographical regions of The Netherlands. We constructed
the sample so as to reflect the national distribution of
urbanization and population density. In order to be able to
study age and gender differences, we stratified the sample for
age and gender. We excluded persons aged 85 and older from
the baseline sample, because the attrition rate of this age group
was expected to be high over the 10-year study period. We
weighted the baseline sample according to expected mortality
in each age group, resulting in an overrepresentation of older
age strata and a roughly even distribution of men and women.
The respondents were visited at home by trained interviewers
who worked with laptop computers. Interview and tests took
approximately 1.5 hr. In the baseline LASA interview, which
took place in 1992–1993, there were 3,107 participants. The
first follow-up measurement was performed in 1995–1996 (n¼
2,545, 82%), and the second in 1998–1999 (n¼ 2,076, 67%).
In the LASA interview, we measured the personality factor
Neuroticism by using a self-report questionnaire. The baseline
LASA cycle consisted of a face-to-face main interview, after
which the interviewer left a questionnaire to be returned by
mail. Not all respondents complied, and to be eligible for
inclusion in the statistical analyses of the present study, the
respondents should have answered more than 80% of all the
items on the questionnaire. This cutoff point resulted in
a sample of 2,117 participants at baseline (68.3%). The older
old (v2 ¼ 158.13; p , .001) and less educated (v2 ¼ 41.55;
p, .001) were more often lost through item nonresponse. Non-
responders had a higher number of chronic diseases (v2¼ 12.7;
p , .001), were more often cognitively impaired (v2¼ 217.17;
p , .001), and showed more difficulties while performing
activities of daily living (v2¼ 74.26; p , .001).
For the multilevel analyses, we used 2,117 cases at baseline,
and 1,983 and 1,647 cases at first and second follow-up
measurement. Data were available for 1,229 respondents on all
three measurements. These 1,229 respondents had a higher
mean age (v2 ¼ 328.86; p , .001), and they were more often
male (v2 ¼ 4.827, p , .05) and higher educated (v2 ¼ 13.62,
p , .001). They reported fewer chronic diseases (v2 ¼ 49.23,
p , .001) and functional limitations (v2¼ 118.306, p , .001)
at baseline in comparison with those respondents lost during
follow-up. Finally, respondents lost during follow-up were
more often cognitively impaired (v2¼ 83.25, p , .001), but we
found no significant difference in mean neuroticism level at
baseline (v2¼ 1.49, p¼ .22).
Measurements
Neuroticism.—We operationalized neuroticism by using
a subset of 25 items out of a list of 36 neuroticism items from
the Dutch Personality Questionnaire (DPQ; Luteijn, Starren, &
van Dijk, 1975, 2000). The pilot studies of the LASA program
showed that the original 36-item scale measuring neuroticism
can be abbreviated, because the original DPQ scale contained
items that were less valid for an aging population and contained
too many items for administration in older populations (de
Beurs, Beekman, Deeg, van Dyck, & van Tilburg, 2000; Smits,
Deeg, & Bosscher, 1995; Steunenberg, Beekman, Deeg, &
Kerkhof, 2003). Persons scoring high on neuroticism items
experience a broad range of negative moods, including
emotions such as fear, sadness or depression, and self-
dissatisfaction. High scorers are socially ill at ease and feel
they cannot easily relate to other people, experience an inability
to inhibit cravings, and are more vulnerable to stress (Costa &
McCrae, 1980, 1984a; Luteijn et al., 2000). An example of
a neuroticism item is ‘‘I often hate myself.’’ Interviewers asked
respondents to indicate whether various similar statements
applied to them (yes¼2, do not know¼1, no¼0). Total scores
range between 0 and 50. These DPQ items have strong negative
relations with the Emotional Stability scale of the Revised NEO
Personality Inventory (NEO-PI-R; Luteijn et al., 2000). We
tested the utility and psychometric properties of the shortened
scale, and it appeared to be a reliable (Cronbach’s a ¼ .86)
and valid instrument to measure neuroticism in the elderly
population (Steunenberg et al., 2003).
Independent variables.—We analyzed demographic varia-
bles and physical health-related variables for their association
with stability or change of the level of neuroticism. We
determined the presence of chronic diseases by asking the
respondents whether they had any of the following diseases:
cardiac disease; peripheral atherosclerosis of the abdominal
aorta or the arteries of the lower limb; stroke; diabetes mellitus;
lung disease (asthma or chronic obstructive pulmonary
disease); malignant neoplasms; arthritis (rheumatoid arthritis
or osteoarthritis); or any other major chronic diseases (Central
Bureau of Statistics, 1989). We calculated the number of
chronic diseases by summing up all specific diseases reported
to be present. In a validation study, respondents’ self-reports
were compared with information obtained from their general
practitioners, and this proved to be sufficiently reliable
(Kriegsman, Penninx, Eijk, Boeke, & Deeg, 1996). For the
present study, the presence of chronic diseases was indicated as
0¼ no disease, 1¼ one disease, and 2¼more than one disease.
We measured cognitive functioning by means of the Mini-
Mental State Examination (MMSE; Folstein et al., 1975),
a frequently used screening instrument for global cognitive
dysfunctioning. On 23 questions and tasks, respondents
received 1 or more points when they gave the correct answer
or performed the task correctly. Scores ran from 0 (all answers
incorrect) to 30 (unimpaired). We divided respondents into two
categories: MMSE , 24 (impaired cognition, 0) and MMSE 
24 (normal cognition, 1).
We assessed functional limitations by asking the respondent
the degree of difficulty he or she had with the following
activities of daily living: climbing up and down a staircase of 15
steps without stopping, cutting one’s own toenails, and using
public transportation (Kriegsman, van Eijk, & Penninx, 1997;
van Sonsbeek, 1988). Response categories were ‘‘yes, without
difficulty,’’ ‘‘yes, with difficulty,’’ ‘‘only with help,’’ and ‘‘no,
I cannot.’’ The number of limitations ranges from zero (low) to
three (high). For this study, the presence of functional limitations
was indicated as 0 ¼ no functional limitations, 1 ¼ one func-
tional limitation, and 2¼more than one functional limitation.
The demographic variables included age group, gender, and
level of education. Age ranged between 55 and 85 at baseline;
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for the purpose of data analyses, we categorized age in three
age groups: 55–64, 65–74, and 75–85. We measured education
on a 3-point ordinal scale: low (elementary or lower vocational
education ¼ 1), middle (general education ¼ 2), and high
(higher vocational, college, or university ¼ 3).
Data Analysis
We analyzed data in three steps. First, we tried to find signif-
icant predictors of mean neuroticism level at baseline. To assess
cross-sectional differences in the mean levels of the neuroticism
scores, we performed univariate analyses of variance (ANOVA).
In order to attain the most parsimonious set of predictors, we
performed a forward-stepwise regression analysis. Although the
observations on the neuroticism items were not normally
distributed, because of the large number of observations the
skewness had only a slight effect on the power of the ANOVAs
and regression analysis (central limit theorism; see Bock, 1975).
Second, we assessed longitudinal changes in mean neuroti-
cism score. To find out how many respondents show a clinically
relevant change in mean neuroticism level during follow-up, we
used a relevant change criterion. Clinical significance refers to
the practical value or importance of the effect of an intervention,
that is, whether it makes any real difference to the clients or to
others in their functioning and everyday life. We defined
a relevant clinical change as a decrease or increase of at least 8
points on the DPQ between two measurements. The difference
of 8 points represents, in clinical terms, a large change (Lipsey &
Wilson, 1993). It is greater than 5, which, on this scale,
corresponds to the threshold for statistically significant change
(Drenth, 1972; Jacobsen & Truax, 1991).
The third data analytic approach that we used in this study was
multilevel analysis. We investigated the longitudinal stability or
change of neuroticism with aging by using a multilevel analysis
(also known as random coefficient analysis; see Goldstein, 1995;
MlwiN, version 1.10.0007; Centre for Multilevel Modeling,
Institute of Education, London). We performed this type of
analysis because this statistical technique makes it possible to
analyze longitudinal relationships by using all available
longitudinal data, without summarizing the longitudinal de-
velopment of each subject into one value. In contrast to the more
traditional methods of longitudinal data analysis (i.e., a multi-
variate analysis of variance, or MANOVA, for repeated mea-
sures), which require a complete longitudinal data set, in
a multilevel analysis, both the number of observations per in-
dividual as well as the time interval between observations may
vary. Multilevel analysis does not use strict conditions con-
cerning the type of missing data, because it assumes data
missing at random: that is, given the observed data, the un-
observed data are random.
In the present study, we defined a two-level hierarchy to form
random regression models to describe the individual variability
in the longitudinal development of neuroticism in an aging
population. The first level is defined by age (range 55–85) and
the second level by the respondents. Because the neuroticism
score was highly skewed, we performed the longitudinal
analyses by using a logarithmic transformation.
We entered both the outcome variable of neuroticism as well
as age as continuous variables. We included age in all models,
in order to test the influence of aging on the neuroticism score.
We tried to find the best model for neuroticism in aging. After
assessing the ‘‘crude’’ linear association of neuroticism with
aging, we added a quadratic age effect to the model (Model 1).
Model 1:
lnðneuroticism scoreÞ ¼ b0ij þ b1ij ageþ b2ij age2;
b0ij ¼ b0 þ u0ij þ e0ij:
We adjusted the statistical model by adding covariates,
considering first gender, level of education (because level of
education is a variable with three categories, two dummy
variables were entered to the equation), number of chronic
diseases, functional limitations, and cognitive functioning in
order to analyze whether these variables influence the
longitudinal development of neuroticism.
Model 2 (adjusted for all covariates):
lnðneuroticism scoreÞ
¼ b0ij þ b01ij ageþ b02ij age2 þ b03 ðgenderÞ
þ b04ðmiddle level of educationÞ
þ b05ðhigh level of educationÞ
þ b06ðchronic diseasesÞ þ b07ðfunctional limitationsÞ
þ b08ðcognitive functioningÞ;
b0ij ¼ b0 þ u0ij þ e0ij:
In the third step, to identify significant predictors of individ-
ual differences in change, we entered the interaction terms
between the physical health-related variables and age into the
model.
RESULTS
Table 1 summarizes the demographic and physical health-
related characteristics of the baseline sample. At inclusion, the
mean age of the 2,117 respondents was 70 years; 51% were
female. The age group and gender distributions are the results
of the stratified sampling. The high number of participants with
a chronic illness (60%) or physical functional limitations (41%)
is a function of the oversampling among the older old. It dem-
onstrates that attrition has not led the participants to become
a sample of ‘‘healthy elderly’’ persons. Table 1 contains the
distribution of average neuroticism scores by demographic and
physical health-related variables, and the results of the uni-
variate ANOVA are summarized in this table.
We found no significant association between age group and
the mean score on neuroticism (p ¼ .158). The age groups do
show an increase in mean level of neuroticism with age, but this
linear association was not significant. Women scored signifi-
cantly higher on the neuroticism factor (p , .001), and
respondents with a middle or higher education scored sig-
nificant lower than the lower educated respondents (p , .001).
The cognitively impaired respondents (MMSE  24) showed
a significant higher level of neuroticism than those with
a normal cognitive functioning (p , .01). We found significant
associations with the number of chronic diseases (p , .001)
and functional limitations (p , .001). The more chronic
diseases and the more functional impaired, the higher the score
on the neuroticism questionnaire was.
The results of the multiple linear regression analysis are
shown in Table 2. The regression equation with four of
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the predictors was significant, R ¼ .25, adjusted R2 ¼ .06,
F(4, 2088) ¼ 34.32, p , .001. The predictors cognitive
functioning (p ¼ .727) and age group (p ¼ .183) showed no
significant relation with neuroticism after the other factors were
controlled for. Functional limitations showed the strongest
association with the mean level of neuroticism. This predictor
alone accounted for 4% of the variance of the baseline level of
neuroticism, whereas the other variables contributed an
additional 2%.
Preceding the longitudinal multilevel analyses on effects of
aging on neuroticism, as a kind of explorative test–retest, we
calculated Pearson correlation coefficients between the total
mean scores on neuroticism for the three measurements. We
deleted respondents listwise, leaving 1,229 respondents who
conducted all three measurements. For the period between
baseline and first follow-up (mean interval of 3 years), we found
a coefficient of .75; for the period between baseline and the
second follow-up (mean interval of 6 years), we found
a coefficient of .77 (results not shown). These test–retest
coefficients are rather high and stable over the 6-year follow-up
period, indicating a stability of test scores over time.We adjusted
the coefficients for baseline age, gender, level of education,
number of chronic diseases, functional limitations, and cognitive
functioning. The associations were hardly affected by these
adjustments and remained stable. The coefficients ranged
between .73 and .77.
In Table 3, we present the neuroticism mean score differences
between baseline and first or second follow-up, answering the
question of how many respondents show a clinically significant
change. We categorized respondents by the strength of the effect
size of this mean-level change. A large majority of nearly 90%
shows a small to medium effect size (d  .90), indicating
stability. A great effect size (difference of more than 8 points) is
seen as a significant clinical change in mean neuroticism level;
4.6% of the respondents between baseline and first follow-up or
second follow-up show a clinically significant decrease, and
7.8% of the respondents between baseline and first follow-up
and 6.6% of the respondents between baseline and second
follow-up show a clinically relevant increase of neuroticism
level.
Table 4 presents the coefficients and standard errors from
multilevel models of individual differences in the longitudinal
development of neuroticism in an aging population. We found
all coefficients to be significant (p , .05). Table 4 should be
interpreted as follows: for any specific age one can, by means of
the coefficients and random variances, compute the sum of the
regression equations, and this sum has to be returned to the
base-e logarithmic (ln) to get the mean neuroticism score for
this specific age. The results as presented in Table 4 are
depicted in Figure 1. This figure shows the crude and adjusted
longitudinal development of the mean neuroticism score in the
research population aged between 55 and 85 years. The
longitudinal multilevel analyses report a statistically significant
change in mean neuroticism level with age. The figure depicts
a U-formed shape, showing a slight decrease until the age of 70
(1.5 DPQ points), after which a slight increase is found until the
age of 85 (increase of 1.5 DPQ points). The mean scores at age
55 and 85 are nearly the same. Adjusting for age group, gender,
Table 1. Neuroticism Scores at Baseline Against Demographic
Characteristics and Health-Related Variables
Characteristic n %
Avg. Neuroticism Score
M (SD) F
Score neuroticism 2,117 100 11.70 (8.85)
Age group (years; M ¼ 69.5)
55–64 774 37 11.30 (8.50) F2, 2114 ¼ 1.85
65–74 711 33 11.73 (9.17)
75–85 632 30 12.21 (8.93)
Gender
Male 1,042 49 10.66 (8.85) F1, 2115 ¼ 29.8***
Female 1,076 51 12.75 (8.76)
Education
Low 1,259 59 12.64 (9.34) F2, 2112 ¼ 18.5***
Middle 592 28 10.62 (7.93)
High 265 13 9.70 (7.75)
No. of chronic diseases (M ¼ 0.93)
None 852 40 10.47 (8.38) F2, 2113 ¼ 27.9***
One 759 36 11.81 (8.33)
More than one 505 24 13.69 (10.00)
General cognitive functioning (M ¼ 27.3)
MMSE , 24 145 7 13.41 (9.36) F1, 2109 ¼ 5.76*
MMSE 24 1,966 93 11.59 (8.80)
Functional limitations (M ¼ 0.64)
None 1,793 59 10.38 (8.34) F2, 2100 ¼ 44.3***
One 584 19 13.22 (8.92)
More than one 685 22 14.74 (9.51)
Note: MMSE¼Mini-Mental State Examination (score).
*p , .05; **p , .01; ***p , .001.
Table 2. Predictors of Neuroticism: Multivariate
Regression Analysis
Independent Variables SRC R Cum
Adjusted
R2 Cum
1. Functional limitations .145 .199 .039*
2. Level of education .093 .226 .050*
3. Gender .081 .239 .056*
4. No. of chronic diseases .073 .248 .060*
F(4, 2088) ¼ 34.31, p , .001
Notes: This is a multiple linear regression; dependent variable of neuroti-
cism (Dutch Personality Questionnaire), n ¼ 2,093. R Cum ¼ cumulative
amount of explained variance; SRC ¼ standardized regression coefficient.
*p , .05.
Table 3. Changes in Mean Level of Neuroticism
Categorized by Effect Size
Effect Size:
 (Mean Neuroticism Score)
No. of Respondents
Baseline to
First Follow-Up
Baseline to
Second Follow-Up
Great decline (d  0.9) 57 (4.6) 57 (4.6)
Medium to great decline (0.9d  0.5) 83 (6.8) 99 (8.1)
Small to medium decline (0.5d  0.2) 136 (11.1) 159 (12.9)
No change 552 (44.9) 543 (44.2)
Small to medium increase (0.2d  0.5) 198 (16.1) 174 (14.2)
Medium to great increase (0.5d  0.9) 107 (8.7) 116 (9.4)
Great increase (d  0.9) 96 (7.8) 81 (6.6)
Notes: n ¼ 1,229. Baseline to first follow-up, mean interval ¼ 3 years;
baseline to second follow-up, mean interval ¼ 6 years. Great decline and
great increase show a clinically significant change. Percentages are shown in
parentheses.
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level of education, cognitive functioning, and number of
chronic diseases and functional limitations hardly influenced
the development of neuroticism in aging, and in general little to
no change in mean neuroticism level is shown in late life. The
mean-level change for the total sample is about 2 points, so
using the relevant change criterion, we find that the mean-level
change is not clinically significant. Because we tried to model
the longitudinal development of neuroticism in an aging
population, the range of mean neuroticism scores, as presented
in Figure 1, decreases if compared with the cross-sectional
baseline range as presented in Table 1.
In the final analyses step, we added the interaction terms of
physical health-related variables to find out if these variables
were significant predictors of individual differences in change.
The variables entered were cognitive functioning, number of
chronic diseases, and number of functional limitations. All
three variables were not associated with individual differences
in changes of neuroticism level. Therefore, the individual
longitudinal trajectory of neuroticism in late life is not affected
by the number of chronic diseases, functional limitations, or
level of cognitive functioning.
DISCUSSION
The overall conclusion that can be drawn from this study is
that, for a majority, neuroticism remains rather stable in old
age; for those who do change, the level of change is not
affected by the deteriorations of physical health or cognitive
functioning known to be related to aging. Although we
hypothesized that we would find an increase of the mean level
with aging, on baseline we found no significant association
between age group and the mean score of neuroticism. In
addition, in the multiple regression analyses, we found age
group not to be associated with neuroticism level. Thus, at
a cross-sectional level, we did not find a significant association
between aging and neuroticism, indicating a stability of mean
neuroticism level. In addition to this, the absolute magnitude of
the test–retest coefficients in this study was rather high (.75),
even when we adjusted it for demographic and physical health-
related variables found to be related to the mean level of
neuroticism, indicating a stability in neuroticism score over
time. These coefficients were similar to those reported
elsewhere, and which are seen as evidence for the stability
assumption (Costa & McCrae, 1988).
However, the longitudinal multilevel analysis reports
a statistically significant change with aging. We found a U-
formed course, showing a slight decrease until the age of 70
and a slight increase after this age. This U-formed course is
very hard to explain. In general there are two possible
explanations for changes in mean score in late life. The first
possible explanation is a survivor effect. The longitudinal
results indicate an effect of physical health on the stability of
neuroticism, whereas adjusting the regression model for
number of functional limitations slightly increases the stability
of the development of neuroticism in an aging population. The
more frail elderly individuals were more often lost by attrition.
The respondents who were lost by attrition during follow-up
showed significantly more difficulties while performing daily
living activities. Costa & McCrae (1985) show that respondents
who have a higher number of chronic diseases or functional
limitations are higher in neuroticism. The decline in mean level
of neuroticism might be explained by the attrition of the most
frail elderly individuals, suggesting that those respondents who
continue the study are the more healthy respondents. The slight
increase after the age of 70 may be explained by an aging
effect. Aging is known to be associated with an increase of
physical illness and associated functional limitations, and
a decrease of social resources. These factors are also known
to be related with the mean neuroticism level (Costa and
McCrae, 1985, 1988).
The mean neuroticism-level change for the total sample
found in the longitudinal multilevel analyses was about 2 DPQ
points, which proved to be statistically significant, but it is
rather small and, according to our relevant change criterion,
cannot be seen as a clinically significant change (Drenth, 1972;
Jacobsen & Truax, 1991; Lipsey & Wilson, 1993).
The degree of change and the impact of that change are
important for deciding clinical relevance. Merely examining the
absolute level of change is not always enough to determine
whether the difference or change really makes a difference.
Table 4. Coefficients and Standard Errors From Multilevel Models of Individual Differences in the
Longitudinal Development of (ln) Neuroticism in an Aging Population
Variable
Unadjusted
(Model 1)
Model Adjusted for
Gender (Model 2)
Level of
Education
No. of Chronic
Diseases
No. of Functional
Limitations
Cognitive
Functioning
Model Adjusted
for all Covariates
Fixed parameters
Intercept, b0ij 5.86 (.82) 5.30 (.81) 5.64 (.79) 5.59 (.78) 5.52 (.82) 5.75 (.81) 5.31 (.80)
Age, b01 0.11 (.02) 0.10 (.02) 0.10 (.02) 0.10 (.02) 0.09 (.02) 0.10 (.02) 0.09 (.02)
Age2, b02 0.0008 (0.0002) 0.0007 (0.0002) 0.0007 (0.0002) 0.0007 (0.0002) 0.0007 (0.0002) 0.0007 (0.0002) 0.0006 (0.0002)
Gender, b03 0.24 (0.03) 0.20 (0.35)
Middle level of education, b04 0.12 (.04) 0.10 (0.04)
High level, b05 0.17 (0.05) 0.11 (0.05)
No. of chronic diseases, b06 0.05 (0.01) 0.03 (0.01)
No. of functional limitations, b07 0.09 (0.02) 0.06 (0.02)
Cognitive functioning, b08 0.04 (.05) 0.01 (0.04)
Random variances
Intercept, u0ij 0.65 (0.02) 0.63 (0.02) 0.64 (0.02) 0.64 (0.02) 0.63 (0.02) 0.65 (0.02) 0.61 (0.02)
Error, e0ij 0.25 (0.01) 0.25 (0.01) 0.25 (0.01) 0.25 (0.01) 0.25 (0.01) 0.25 (0.01) 0.25 (0.01)
Note: no significant changes of the models were observed by adding random variances for age and age2.
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A mean change of 2 points on a scale with a maximum score
of 50 is small, and the impact on everyday performance is
negligible. Preceding these multilevel analyses, we analyzed
how many respondents did change, using a clinically relevant
change criterion. Of all the respondents, 5% showed a clinically
significant decrease and 7% an increase.
Finally, we searched for significant predictors of individual
differences in changes in neuroticism trajectories. None of the
physical health-related variables were associated with in-
dividual differences in neuroticism trajectories. In other words,
for those respondents who do change, the mean level of
neuroticism is not affected by the number of chronic diseases,
functional limitations, or level of cognitive functioning. A
recent study by Mroczek and Spiro (2003) also found no
significant association for functional limitations.
The strengths of this study are the large study population (n¼
2,117) and the prospective follow-up design. The present study
is one of the first 6-year longitudinal designs, investigating age
changes and differences in the personality dimension neuroti-
cism in a large, representative population of elderly persons.
Because of the multidisciplinary design of the LASA study, we
found it not only possible to examine the relationship between
the level of neuroticism and the demographic characteristics, but
we could also study whether physical health-related character-
istics did influence the stability of neuroticism in the aging.
A limitation of the present study is the large number of
respondents lost by attrition (31.7%). As in all community-
based studies of elderly persons, the older old and less
educated, those with cognitive impairments, and the respond-
ents with more chronic diseases and difficulties while perform-
ing daily living activities were more often lost through attrition,
which may threaten the generalizability of the results.
In summary, we can conclude that neuroticism remains
rather stable in old age. In the cross-sectional analyses, age
shows no significant association with neuroticism. The
magnitude of the stability coefficient is high and in line with
findings supporting the stability assumption (Costa & McCrae,
1988, 1994); 12% of the elderly individuals show a clinically
relevant change. Finally, the longitudinal change found to be
statistically significant cannot be considered clinically relevant
(Drenth, 1972; Jacobsen & Truax, 1991; Lipsey & Wilson,
1993). In addition to this, we hypothesized that we would find
significant influences of age-graded deteriorations in physical
health and related declines in daily functioning on individual
trajectories of neuroticism. However, our results showed that
individual differences in change of neuroticism in late life are
not affected by individual differences in physical health-related
variables. In conclusion, neuroticism remains rather stable in
very old age; although we did find significant individual
differences in trajectories, we could not explain these differ-
ences by late-life increase in physical illness and associated
functional limitations.
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